rs756434530

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 2P and 7B. PM1BP4_ModerateBS1_SupportingBS2

The NM_001159702.3(FHL1):​c.292T>A​(p.Ser98Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000381 in 1,208,261 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S98P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000040 ( 0 hom. 9 hem. )

Consequence

FHL1
NM_001159702.3 missense

Scores

4
13

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 1.55
Variant links:
Genes affected
FHL1 (HGNC:3702): (four and a half LIM domains 1) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. Expression of these family members occurs in a cell- and tissue-specific mode and these proteins are involved in many cellular processes. Mutations in this gene have been found in patients with Emery-Dreifuss muscular dystrophy. Multiple alternately spliced transcript variants which encode different protein isoforms have been described.[provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 8 uncertain in NM_001159702.3
BP4
Computational evidence support a benign effect (MetaRNN=0.1392864).
BS1
Variant frequency is greater than expected in population amr. gnomad4_exome allele frequency = 0.0000401 (44/1096082) while in subpopulation AMR AF= 0.000142 (5/35137). AF 95% confidence interval is 0.0000553. There are 0 homozygotes in gnomad4_exome. There are 9 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Hemizygotes in GnomAdExome4 at 9 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
FHL1NM_001159702.3 linkuse as main transcriptc.292T>A p.Ser98Thr missense_variant 4/8 ENST00000394155.8
FHL1NM_001159699.2 linkuse as main transcriptc.340T>A p.Ser114Thr missense_variant 3/6 ENST00000370683.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
FHL1ENST00000394155.8 linkuse as main transcriptc.292T>A p.Ser98Thr missense_variant 4/85 NM_001159702.3 Q13642-2
FHL1ENST00000370683.6 linkuse as main transcriptc.340T>A p.Ser114Thr missense_variant 3/61 NM_001159699.2 P1Q13642-5

Frequencies

GnomAD3 genomes
AF:
0.0000178
AC:
2
AN:
112179
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34355
show subpopulations
Gnomad AFR
AF:
0.0000324
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000550
AC:
10
AN:
181669
Hom.:
0
AF XY:
0.0000603
AC XY:
4
AN XY:
66389
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000183
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000125
Gnomad NFE exome
AF:
0.0000371
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000401
AC:
44
AN:
1096082
Hom.:
0
Cov.:
31
AF XY:
0.0000249
AC XY:
9
AN XY:
361616
show subpopulations
Gnomad4 AFR exome
AF:
0.0000379
Gnomad4 AMR exome
AF:
0.000142
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000988
Gnomad4 NFE exome
AF:
0.0000357
Gnomad4 OTH exome
AF:
0.0000870
GnomAD4 genome
AF:
0.0000178
AC:
2
AN:
112179
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34355
show subpopulations
Gnomad4 AFR
AF:
0.0000324
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000188
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000843
Hom.:
0
Bravo
AF:
0.0000340
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

X-linked myopathy with postural muscle atrophy Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJun 15, 2022This sequence change replaces serine, which is neutral and polar, with threonine, which is neutral and polar, at codon 98 of the FHL1 protein (p.Ser98Thr). This variant is present in population databases (rs756434530, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with FHL1-related conditions. ClinVar contains an entry for this variant (Variation ID: 222634). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Primary familial hypertrophic cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingBlueprint GeneticsJun 30, 2015- -
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 03, 2022The p.S98T variant (also known as c.292T>A), located in coding exon 2 of the FHL1 gene, results from a T to A substitution at nucleotide position 292. The serine at codon 98 is replaced by threonine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
15
DANN
Uncertain
0.97
DEOGEN2
Benign
0.30
.;T;.;T;.;T;T;T;.;.;T;.;T;.;.;T;.;T;T;.;.;.;T;T;.
FATHMM_MKL
Benign
0.21
N
LIST_S2
Benign
0.76
.;T;.;T;T;T;T;T;T;.;.;.;T;.;T;T;T;T;.;.;T;T;T;T;.
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.14
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.47
T
MutationAssessor
Benign
0.27
N;N;N;.;N;.;.;.;.;N;.;N;.;N;N;.;.;.;N;.;.;.;.;.;N
MutationTaster
Benign
1.0
N;N;N;N;N;N;N;N;N
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-1.9
.;N;N;.;.;N;N;.;.;.;N;N;N;N;N;N;.;N;N;.;N;N;N;N;.
REVEL
Benign
0.20
Sift
Uncertain
0.026
.;D;D;.;.;D;D;.;.;.;D;D;D;D;D;D;.;D;D;.;D;D;D;D;.
Sift4G
Uncertain
0.034
D;T;D;T;T;T;D;T;T;D;T;D;T;D;D;D;T;T;T;T;D;D;T;D;D
Polyphen
0.0040, 0.0010
.;B;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;B;.;.;.;B;.;.
Vest4
0.32
MVP
0.87
MPC
0.47
ClinPred
0.043
T
GERP RS
3.4
Varity_R
0.23

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs756434530; hg19: chrX-135289310; API